Becton Dickinson - 50 Year Dividend History | BDX

Historical dividend payout and yield for Becton Dickinson (BDX) since 1975. The current TTM dividend payout for Becton Dickinson (BDX) as of April 30, 2025 is $4.16. The current dividend yield for Becton Dickinson as of April 30, 2025 is 2.02%.
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $59.276B $20.178B
Becton, Dickinson and Company, is a medical technology company engaged principally in the development, manufacture and sale of medical devices, instrument systems and reagents. BD's operations consisted of three business segments: BD Medical, BD Diagnostics and BD Biosciences. The company's organizational structure was realigned to form two principal business segments: BD Medical, BD Life Sciences and BD Interventional. BD Medical: BD Medical's major product lines include needles, syringes and intravenous catheters for medication delivery and generic prefilled injectables. BD Life Sciences - BD Diagnostics provides products for the safe collection and transport of diagnostics specimens to detect a broad range of infectious diseases, healthcare-associated infections and cancer. BD Biosciences produces research and clinical tools that facilitate the study of cells to gain a better understanding of normal and disease processes. With the acquisition of C.R. Bard, BD added a new segment - BD Interventional.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $88.641B 24.25
Cardinal Health (CAH) United States $33.781B 18.09
Labcorp (LH) United States $20.116B 16.32
Straumann Holding AG (SAUHY) Switzerland $19.852B 0.00
Cooper (COO) United States $16.444B 21.81
West Pharmaceutical Services (WST) United States $15.336B 32.15
Align Technology (ALGN) United States $13.013B 25.21
Henry Schein (HSIC) United States $8.105B 13.96
Merit Medical Systems (MMSI) United States $5.600B 27.07
DENTSPLY SIRONA (XRAY) United States $2.780B 8.35
CONMED (CNMD) United States $1.583B 12.30
STAAR Surgical (STAA) United States $0.918B 0.00
Pro-Dex (PDEX) United States $0.217B 33.03
Lifevantage (LFVN) United States $0.155B 17.15